.png)
A Smart Drug Delivery Platform
Peptinovo’s novel peptide-based delivery platform, uses cancer’s growth pathway to safely carry stronger doses of proven drugs directly into tumors while keeping them away from healthy tissue.
Peptinovo’s novel peptide-based delivery platform, uses cancer’s growth pathway to safely carry stronger doses of proven drugs directly into tumors while keeping them away from healthy tissue.
We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy paclitaxel). Three additional chemotherapy drugs have been developed and are ready to enter pre-IND.
Peptinovo’s seasoned team has launched three drugs from idea to market, started seven individual pharma companies, and led all aspects needed to develop, test, and launch pharmacology products.
We look forward to talking with you.